The clinical significance of the involvement of CDK10 in the response of MCF7 breast cancer cells to tamoxifen was investigated by measuring CDK10 expression levels in tumors from breast cancer patients subjected to an endocrine therapy [10]. Here, CDK10 is linked to breast carcinoma.